{
    "eid": "2-s2.0-84986233873",
    "title": "Acceptability, tolerability, and satisfaction of a contraceptive vaginal ring (the NuvaRing) among Thai women",
    "cover-date": "2016-06-01",
    "subject-areas": [
        {
            "$": "General Biochemistry",
            "@code": "1300"
        },
        {
            "$": "General Medicine",
            "@code": "2700"
        }
    ],
    "keywords": [
        "Acceptability",
        "Contraceptive vaginal ring",
        "NuvaRing",
        "Satisfaction",
        "Tolerability"
    ],
    "authors": [
        "Somsook Santibenchakul"
    ],
    "citedby-count": 4,
    "ref-count": 19,
    "ref-list": [
        "The Reproductive Health Survey",
        "Berek and Novak's Gynecology",
        "Adolescents\u2019 Compliance With the Use of Oral Contraceptives",
        "Thai J Obstet Gynecol.",
        "Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring",
        "NuvaRing (For U.S. Health Care Professionals)",
        "Complete and robust ovulation inhibition with NuvaRing",
        "Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol",
        "Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing",
        "Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study",
        "Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring",
        null,
        "Medical Eligibility Criteria for Contraceptive Use",
        null,
        "Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol",
        "Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring",
        "Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: A 1-year randomized trial",
        "Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 \u03bcg of ethinyl estradiol and 3 mg of drospirenone",
        "The combined contraceptive vaginal device (NuvaRing\u00ae): A comprehensive review"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Honolulu",
            "affilname": "University of Hawai\u02bbi at M\u0101noa",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Honolulu",
            "affilname": "East-West Center",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}